EXHIBIT 4.2 PLACEMENT AGENTS WARRANT AGREEMENT This WARRANT AGREEMENT (this "Agreement") dated November 7, 2005, by and among Javelin Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Rodman & Renshaw, LLC ("R&R"), and Riverbank...Placement Agents Warrant Agreement • November 10th, 2005 • Javelin Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Placement Agent’s Warrant AgreementPlacement Agent’s Warrant Agreement • October 27th, 2021 • Creatd, Inc. • Services-allied to motion picture production
THIS WARRANT TO PURCHASE COMMON STOCK (the “Warrant”) certifies that, for value received, THE BENCHMARK COMPANY, LLC, or its assigns (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April 27, 2022 (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(f)(2)(G)(i), prior to October 27, 2027 at 5:00 p.m. (New York time) (the “Termination Date”) but not thereafter, to subscribe for and purchase from CREATD, INC., a Nevada corporation (the “Company”), up to 42,500 shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENT’S WARRANT AGREEMENTPlacement Agent's Warrant Agreement • June 29th, 2023 • Mobiquity Technologies, Inc. • Services-advertising • New York
THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE COMMENCEMENT OF SALES OF THE OFFERING TO ANYONE OTHER THAN (I) SPARTAN CAPITAL SECURITIES, LLC, OR A REPRESENTATIVE OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF SPARTAN CAPITAL SECURITIES, LLC, OR OF ANY SUCH SELECTED DEALER.
Form of Placement Agent’s Warrant AgreementPlacement Agent’s Warrant Agreement • October 31st, 2017 • Soligenix, Inc. • Pharmaceutical preparations • New York
THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS 180 DAYS FROM THE CLOSING DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE CLOSING DATE OF THE OFFERING].
Form of Placement Agent’s Warrant AgreementPlacement Agent’s Warrant Agreement • September 16th, 2024 • Vision Marine Technologies Inc. • Ship & boat building & repairing
THIS WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, [--] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March 15, 2025 (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(g)(8)(A), prior to at 5:00 p.m. (New York time) on the date that is five (5) years following the Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Vision Marine Technologies Inc., a Quebec corporation (the “Company”), up to 29,290 Common Shares, without par value per share, of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
